Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CVD EQUIPMENT CORPCVV · Entity 7247 | VP Sales & Marketing | March 23, 2023 | June 01, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CVD EQUIPMENT CORP
Report date March 23, 2023 · Filed June 01, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Options to purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $14.11 · Expires 2033-03-23 | Direct | 15,000 |
Reported balance
After 2023-03-23 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-03-23 · Grant · Acquired 15,000 · Balance 15,000 F1: The Reporting Person's stock options vest in four equal installments of 25% on the first, second, third, and fourth anniversary of the initial grant date of March 23, 2023 |
Filing footnotes · ownership attribution and instrument terms
F1: The Reporting Person's stock options vest in four equal installments of 25% on the first, second, third, and fourth anniversary of the initial grant date of March 23, 2023
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 23, 2023 Filed Jun 1, 2023 19:07 UTC | CVD EQUIPMENT CORP CVV · Entity 7247 | GrantOptions to purchase Common Stock · Derivative | 15,000 | $0.00 Strike: $14.11 | $0.00 |
DisclosureSEC source: 0000766792-23-000003 · primary_doc.xml · derivative · entry 1 Brogan Jeffrey Alan · CIK 0001856695 · VP Sales & Marketing 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2033-03-23 F1 · derivative.exercise_date: The Reporting Person's stock options vest in four equal installments of 25% on the first, second, third, and fourth anniversary of the initial grant date of March 23, 2023 Read SEC document |
| August 17, 2022 Filed Aug 24, 2022 19:24 UTC | CVD EQUIPMENT CORP cvv · Entity 7247 | GrantOptions to purchase common stock · Derivative | 15,000 | $0.00 Strike: $5.02 | $0.00 |
DisclosureSEC source: 0000766792-22-000004 · primary_doc.xml · derivative · entry 1 Brogan Jeffrey Alan · CIK 0001856695 · VP Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2032-08-17 F1 · derivative.exercise_date: The Reporting Person's stock options vest in four equal installments of 25% on the first, second, third, and fourth anniversary of the initial grant date of August 17, 2022. Read SEC document |
| July 15, 2021 Filed Jul 16, 2021 18:59 UTC | CVD EQUIPMENT CORP cvv · Entity 7247 | GrantOptions to purchase common stock · Derivative | 20,000 | $0.00 Strike: $4.01 | $0.00 |
DisclosureSEC source: 0001856695-21-000002 · primary_doc.xml · derivative · entry 1 Brogan Jeffrey Alan · CIK 0001856695 · VP Sales & Marketing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2031-07-15 F1 · derivative.exercise_date: vesting of stock options is 25% per year on 7/15/2022, 2023, 2024 and 2025. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.